We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.
- Authors
Stătescu, Cristian; Anghel, Larisa; Tudurachi, Bogdan-Sorin; Leonte, Andreea; Benchea, Laura-Cătălina; Sascău, Radu-Andy
- Abstract
Despite all the important advances in its diagnosis and treatment, acute myocardial infarction (AMI) is still one of the most prominent causes of morbidity and mortality worldwide. Early identification of patients at high risk of poor outcomes through the measurement of various biomarker concentrations might contribute to more accurate risk stratification and help to guide more individualized therapeutic strategies, thus improving prognoses. The aim of this article is to provide an overview of the role and applications of cardiac biomarkers in risk stratification and prognostic assessment for patients with myocardial infarction. Although there is no ideal biomarker that can provide prognostic information for risk assessment in patients with AMI, the results obtained in recent years are promising. Several novel biomarkers related to the pathophysiological processes found in patients with myocardial infarction, such as inflammation, neurohormonal activation, myocardial stress, myocardial necrosis, cardiac remodeling and vasoactive processes, have been identified; they may bring additional value for AMI prognosis when included in multi-biomarker strategies. Furthermore, the use of artificial intelligence algorithms for risk stratification and prognostic assessment in these patients may have an extremely important role in improving outcomes.
- Subjects
PROGNOSIS; MYOCARDIAL injury; MYOCARDIAL infarction; ARTIFICIAL intelligence; RISK assessment
- Publication
International Journal of Molecular Sciences, 2022, Vol 23, Issue 16, p9168
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms23169168